Effects of Different Biological Therapies on S1/S2 Antibody Response to SARS-CoV-2 Vaccination in a Cohort of Patients with Inflammatory Bowel Disease

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has affected the entire planet. The objectives of our study were to compare responses to the vaccine (Pfizer-Biontech COMIRNATY) in a population of patients with intestinal bowel syndrome undergoing different biological thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Labarile, Nunzia, Castellana, Fabio, Sila, Annamaria, Pesole, Pasqua Letizia, Coletta, Sergio, Curlo, Margherita, Sardone, Rodolfo, Giannelli, Gianluigi, Mastronardi, Mauro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322472/
https://www.ncbi.nlm.nih.gov/pubmed/35891241
http://dx.doi.org/10.3390/vaccines10071077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322472/
https://www.ncbi.nlm.nih.gov/pubmed/35891241
http://dx.doi.org/10.3390/vaccines10071077

Ejemplares similares